Rajitha Gali
National Institute of Technology, Warangal
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rajitha Gali.
Bioorganic & Medicinal Chemistry Letters | 2015
Rajitha Gali; Janardhan Banothu; Ramesh Gondru; Rajitha Bavantula; Yashodhara Velivela; Peter A. Crooks
A series of indole incorporated thiazolylcoumarins (7a-q) have been synthesized and evaluated for their antibacterial, anticancer and DNA cleavage studies. Analysis of antibacterial studies indicated that all the synthesized compounds possess promising activity towards the screened bacterial strains. In vitro anticancerous action was studied for compound 7a (NSC: 768621/1) against the full panel of 60 human tumor cell lines. The five dose level activity results revealed that, the compound 7a was active against all the cell lines among them it has shown potent activity against Leukemia: CCRF-CEM (GI₅₀: 0.33 μM), Non-Small Cell Lung Cancer: NCI-H522 (GI₅₀: 1.03 μM), Colon Cancer: HCT-116 (GI₅₀: 1.60 μM), CNS Cancer: SF-539 (GI₅₀: 1.58 μM), Melanoma MALME-3M (GI50: 1.59 μM), Ovarian Cancer: OVCAR-3 (GI₅₀: 1.16 μM), Renal Cancer: UO-31 (GI₅₀: 0.76 μM), Prostate Cancer: PC-3 (GI₅₀: 0.82 μM) and Breast Cancer: BT-549 (GI₅₀: 1.13 μM). DNA cleavage studies revealed that even at 50 μg/mL concentration complete DNA digestion was observed for all the compounds, except for compound (7o) where partial DNA digestion was observed even at 100 μg/mL.
Bioorganic & Medicinal Chemistry Letters | 2014
Rajitha Gali; Janardhan Banothu; Mahendar Porika; Ravibabu Velpula; Sairengpuii Hnamte; Rajitha Bavantula; Sadanandam Abbagani; Siddhardha Busi
A series of novel 10-((1H-indol-3-yl)methylene)-7-aryl-7,10-dihydro-5H-benzo[h]thiazolo[2,3-b]quinazolin-9(6H)-ones (8a-t) have been synthesized in good yields by the reaction of benzo[h]quinazoline-2(1H)-thiones (4a-f) with 2-chloro-N-phenylacetamide (5) followed by Knoevenagel condensation with various indole-3-carbaldehydes (7a-d) under conventional method. All the synthesized compounds were characterized by spectral studies and screened for their in vitro anticancer and antimicrobial activities. Compound 8c has exhibited excellent activity against MCF-7 (breast cancer cell line) than the standard drug Doxorubicin. Compound 8d against both the cancer cell lines, 8q against MCF-7 and 8c, 8h against HepG2 have also shown good activity. Remaining compounds have shown moderate activity against both the cell lines. Antimicrobial activity revealed that, the compound 8q and 8t against Staphylococcus aureus and 8i, 8k, 8l, 8q &8t against Klebsiella pneumoniae have shown equipotent activity on comparing with the standard drug Streptomycin. Remaining compounds have shown significant antibacterial and comparable antifungal activities against all the tested microorganisms.
RSC Advances | 2014
Rajitha Gali; Janardhan Banothu; Mahendar Porika; Ravibabu Velpula; Rajitha Bavantula; Sadanandam Abbagani
A series of novel coumarinylimidazo[2,1-b]thiazole derivatives were synthesized by the treatment of 3-(2-aminothiazol-4-yl)-2H-chromen-2-one with phenacyl bromides followed by Vilsmeier–Haack and Knoevenagel condensation reactions. Structures of all the newly synthesized compounds were confirmed by their spectral and analytical studies. All the synthesized compounds were screened for their in vitro cytotoxic activity against Breast cancer cell line (MCF-7), Hepatocellular liver carcinoma cell line (HepG2), Cervical carcinoma cell line (HeLa) and Lung cancer cell line (NCI-H460). Cytotoxic activity results revealed that, the compound 4d has shown broad spectrum activity against MCF-7, HepG2 & HeLa with IC50 values 16.99 ± 0.7, 13.92 ± 0.2 & 5.18 ± 0.1 μM respectively. Compound 6 against MCF-7 (IC50 10.83 ± 0.5 μM) and HeLa (IC50 6.77 ± 0.2 μM), 4a, 4c & 5a against HeLa and 5c against NCI-H460 with IC50 values 7.13 ± 0.4, 14.21 ± 0.6, 17.87 ± 0.5 & 16.27 ± 0.5 μM respectively have shown good activity. Remaining compounds have shown moderate activity against all the tested cell lines.
Journal of Chemical Sciences | 2013
Janardhan Banothu; Rajitha Gali; Ravibabu Velpula; Rajitha Bavantula
AbstractA series of novel fused pyrano pyrimidinones were synthesized by the condensation of 2-amino-4-aryl-4H-benzo[h]chromene-3-carbonitriles with 2-oxo-2H-chromene-3-carboxylic acid under neat conditions employing an efficient, eco-friendly and reusable Brønsted acidic ionic liquid, (4-sulfobutyl)tris(4-sulfophenyl)phosphonium hydrogen sulphate as catalyst. All the synthesized compounds were characterized by their analytical and spectroscopic data and they were screened for in vitro antibacterial activity against Bacillus subtilis, Staphylococcus aureus and Staphylococcus epidermidis as Gram- positive, Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumonia as Gram-negative bacterial strains and antifungal activity against Aspergillus flavus, Saccharomyces cerevisiae, Candida rugosa and Candida albicans. Compounds 2c and 2d have shown good antibacterial activity against Escherichia coli while 2g has shown marked antifungal activity against Candida rugosa. Graphical AbstractPyrano pyrimidinones were synthesized by the condensation of 2-amino-4-aryl-4H-benzo[h]chromene-3-carbonitriles with 2-oxo-2H-chromene-3-carboxylic acid in the presence of Brønsted acidic ionic liquid, (4-sulphobutyl)tris(4-sulphophenyl)phosphonium hydrogen sulphate as catalyst. All the synthesized compounds were screened for in vitro antimicrobial activity.
Research on Chemical Intermediates | 2016
Ravibabu Velpula; Rajitha Deshineni; Rajitha Gali; Rajitha Bavantula
A series of novel 1-thiazolyl-5-coumarin-3-yl-pyrazole derivatives (4a–l) were synthesized via one-pot multicomponent reaction of 5-substituted salicylaldehydes (1a–c), 4-hydroxy-6-methyl-2H-pyran-2-one (2) and 2-hydrazinyl-4-arylthiazoles (3a–d) in acetonitrile using a catalytic amount of piperidine under reflux conditions. This multicomponent approach has advantages such as reduced reaction time and a high product yield percentage when compared with corresponding multistep approaches. All the synthesized compounds were evaluated for their cytotoxic activity against Hep G2 (hepatocellular liver carcinoma) and MCF-7 (breast cancer) cell lines and compared with the standard drug Doxorubicin. Among all the compounds, compounds 4d against Hep G2, 4k against MCF-7 and 4e against both Hep G2 & MCF-7 showed excellent cytotoxic activity.
International Scholarly Research Notices | 2013
Janardhan Banothu; Rajitha Gali; Ravibabu Velpula; Rajitha Bavantula; Peter A. Crooks
Highly efficient and eco-friendly protocol for the synthesis of bis(3-indolyl)methanes by the electrophilic substitution reaction of indole with aldehydes catalyzed by poly(4-vinylpyridinium)hydrogen sulfate was described. Excellent yields, shorter reaction times, simple work-up procedure, avoiding hazardous organic solvents, and reusability of the catalyst are the most obvious advantages of this method.
Molecular Diversity | 2018
Ramesh Gondru; Saikiran Reddy Peddi; Vijjulatha Manga; Manjulatha Khanapur; Rajitha Gali; Narsimha Sirassu; Rajitha Bavantula
As a part of our endeavor toward the synthesis of a new class of biologically potent heterocyclic hybrids, a series of newly fused thiazolo[2,3-b]pyrimidinones bearing a pyrazolylcoumarin moiety (6a–p) were synthesized in acceptable yields. Anticipated structures of all titled compounds were in agreement with spectral and analytical (C, H and N) analyses. The compounds were screened for in vitro antibacterial activity against both G+ and G− bacterial strains and antiproliferative activity against K562 (chronic myelogenous leukemia), MCF-7 (breast cancer), MDA-MB-231 (breast cancer), COLO 205 (colorectal adenocarcinoma), HepG2 (hepatocellular carcinoma) cell lines. Further, potent antibacterial compounds were subjected to molecular docking studies in order to gain insight into their plausible binding modes and mechanism of action against MurB. The modeling results were in agreement with the experimental data.Graphical abstract
Tetrahedron Letters | 2013
Janardhan Banothu; Ravibabu Velpula; Rajitha Gali; Rajitha Bavantula; Peter A. Crooks
Chinese Chemical Letters | 2015
Ravibabu Velpula; Janardhan Banothu; Rajitha Gali; Rajitha Deshineni; Rajitha Bavantula
Journal of Heterocyclic Chemistry | 2015
Rajitha Gali; Janardhan Banothu; Rajitha Bavantula